background
influenza
act
synergist
bacteri
copathogen
studi
describ
coinfect
larg
cohort
sever
influenza
infect
object
describ
spectrum
clinic
impact
coinfect
studi
design
retrospect
cohort
studi
patient
sever
influenza
infect
septemb
april
intens
care
unit
us
hospit
compar
characterist
case
without
coinfect
bivari
multivari
analysi
sever
influenza
influenza
coinfect
staphylococcu
aureu
mrsa
icu
result
adult
pediatr
patient
develop
bacteri
coinfect
develop
viral
coinfect
staphylococcu
aureu
common
caus
coinfect
isol
patient
characterist
independ
associ
develop
bacteri
coinfect
adult
patient
logist
regress
model
includ
absenc
cardiovascular
diseas
p
leukocytosi
kl
p
refer
normal
wbc
kl
icu
admiss
higher
icu
admiss
sofa
score
increas
sofa
score
p
bacteri
coinfect
p
viral
coinfect
p
associ
death
bivari
analysi
patient
bacteri
coinfect
longer
hospit
stay
longer
icu
stay
like
greater
delay
initi
antivir
administr
patient
without
coinfect
p
bivari
analysi
conclus
bacteri
coinfect
common
result
delay
antivir
therapi
associ
increas
resourc
alloc
higher
mortal
elsevi
bv
right
reserv
influenza
result
signific
morbid
mortal
us
worldwid
exacerb
bacteri
coinfect
season
pandem
influenza
year
sever
influenza
pandem
record
estim
peopl
die
unit
state
epidemiolog
clinic
patholog
data
indic
major
influenza
patient
die
bacteri
pneumonia
rather
influenza
viru
bacteri
coinfect
thu
studi
order
devis
effect
prevent
therapeut
strategi
influenza
viru
shown
complex
effect
human
lung
prime
respiratori
tract
synergist
pathogenesi
bacteri
coinfect
morbid
mortal
increas
bacteri
pneumonia
complic
influenza
infect
compar
bacteri
pneumonia
absenc
influenza
infect
pandem
streptococcu
pneumonia
like
common
copathogen
pandem
mani
report
identifi
staphylococcu
aureu
frequent
cultur
copathogen
recent
aureu
increasingli
found
case
fulmin
pneumonia
complic
influenza
infect
haemophilu
influenza
introduct
h
influenza
type
b
conjug
vaccin
streptococcu
pyogen
decreas
preval
time
vaccin
novel
antibiot
probabl
importantli
viral
bacteri
strainrel
differ
account
shift
etiolog
common
bacteri
coinfect
novel
pandem
influenza
strain
influenza
emerg
report
rate
bacteri
coinfect
among
sever
ill
patient
vari
communityacquir
influenza
patient
season
studi
combin
communityacquir
hospitalacquir
influenza
patient
studi
common
communityacquir
pathogen
includ
pneumonia
aureu
risk
coinfect
spectrum
bacteri
speci
studi
season
first
postpandem
year
influenza
pdm
predomin
circul
influenza
strain
recent
complet
retrospect
studi
patient
sever
influenza
treat
intens
care
unit
icu
us
hospit
influenza
season
object
present
studi
evalu
bacteri
viral
coinfect
cohort
describ
spectrum
coinfect
determin
clinic
impact
perform
retrospect
cohort
studi
patient
laboratori
confirm
influenza
andor
influenza
b
infect
diagnos
influenza
icu
stay
within
day
prior
icu
admiss
septemb
april
us
studi
site
made
sever
influenza
consortium
shic
laboratori
test
may
pcrbase
test
rapid
test
viral
cultur
complet
laboratori
data
access
infect
control
record
enterpris
data
warehous
directli
clinic
microbiolog
laboratori
institut
review
board
approv
studi
particip
site
data
studi
abstract
physician
center
electron
health
record
ehr
enter
redcap
databas
data
abstract
studi
site
inform
previous
describ
bacteri
coinfect
defin
patient
one
isol
obtain
blood
cultur
andor
pleural
fluid
sputum
tracheal
bronchoscop
sampl
isol
pathogen
thought
caus
true
infect
opinion
treat
physician
isol
collect
within
day
icu
admiss
present
arriv
icu
viral
coinfect
defin
patient
posit
pcr
appropri
antibodi
test
viral
pathogen
influenza
bacteri
coinfect
cultur
within
h
hospit
admiss
defin
communityacquir
cultur
h
consid
hospitalacquir
bacteri
identif
suscept
test
perform
method
determin
institut
guidelin
patient
manag
accord
institut
practic
stata
colleg
station
tx
statacorp
lp
use
analys
outlier
reexamin
ehr
ensur
data
accuraci
subject
outli
valu
exclud
analysi
descript
statist
tabul
bivari
analys
use
compar
potenti
risk
factor
bacteri
coinfect
diagnos
day
icu
admiss
present
admiss
multivari
logist
regress
model
develop
determin
variabl
significantli
associ
bivari
analys
p
independ
miss
data
specif
variabl
n
subject
data
variabl
indic
far
left
column
b
defin
either
respiratori
fluoroquinolon
levofloxacin
moxifloxacin
combin
broadspectrum
betalactam
drug
ceftriaxon
cefepim
ampicillinsulbactam
piperacillintazobactam
carbapenem
azithromycin
c
defin
combin
therapi
target
methicillin
resist
aureu
mrsa
includ
vancomycin
linezolid
second
agent
target
pseudomona
aeruginosa
includ
piperacillintazobactam
ceftazidim
cefepim
carbapenem
except
ertapenem
aztreonam
ciprofloxacin
levofloxacin
colistin
associ
coinfect
multivari
analysi
use
predict
risk
death
among
coinfect
patient
also
assess
resourc
util
account
admiss
sofa
score
five
hundr
seven
patient
sever
influenza
admit
icu
one
us
hospit
particip
shic
studi
cohort
influenza
caus
infect
influenza
viru
subtyp
caus
addit
infect
influenza
strain
caus
infect
tabl
adult
pediatr
subject
baselin
characterist
display
tabl
bacteri
coinfect
present
subject
compris
adult
pediatr
subject
sixti
two
subject
develop
communityacquir
bacteri
coinfect
subject
develop
hospitalacquir
bacteri
coinfect
patient
develop
communityacquir
hospitalacquir
bacteri
coinfect
respect
signific
comorbid
condit
total
bacteri
isol
cultur
patient
cohort
aureu
preval
speci
among
commun
hospitalacquir
pathogen
tabl
fig
preval
aureu
lower
among
hospitalacquir
coinfect
compar
communityacquir
coinfect
contrast
preval
enterobacteriacea
pseudomona
sp
higher
among
hospitalacquir
bacteri
coinfect
respect
compar
communityacquir
bacteri
coinfect
respect
pneumonia
h
influenza
pyogen
isol
among
hospitalacquir
pathogen
present
among
communityacquir
coinfect
respect
patient
characterist
associ
develop
bacteri
coinfect
among
adult
year
age
bivari
analys
shown
tabl
number
children
cohort
develop
bacteri
coinfect
small
assess
risk
factor
coinfect
patient
coinfect
bacteri
pathogen
die
patient
coinfect
bacteri
pathogen
die
bacteri
coinfect
patient
significantli
like
die
p
patient
coinfect
bacteri
pathogen
univari
analysi
control
diseas
sever
sofa
score
patient
coinfect
still
like
die
p
patient
sever
influenza
infect
first
postpandem
season
us
influenza
predomin
circul
influenza
strain
respiratori
coinfect
common
associ
higher
mortal
result
increas
resourc
alloc
defin
longer
hospit
icu
stay
although
signific
account
admiss
sofa
score
studi
patient
sever
influenza
bacteri
coinfect
viral
coinfect
patient
die
onethird
bacteri
coinfect
aureu
preval
speci
caus
respiratori
bacteri
coinfect
mrsa
common
communityacquir
pathogen
support
idea
aureu
synergist
relationship
influenza
even
peopl
commun
patient
bacteri
coinfect
less
like
cardiovascular
diseas
like
leukocytosi
icu
admiss
tend
higher
icu
admiss
sofa
score
cohort
among
patient
bacteri
coinfect
communityacquir
hospitalacquir
coinfect
rate
lower
report
season
pandem
year
rate
communityacquir
coinfect
combin
communityand
hospitalacquir
coinfect
report
although
criteria
defin
coinfect
patient
vari
studi
four
autopsi
cohort
show
evid
bacteri
pneumonia
one
four
patient
posit
cultur
despit
collect
respiratori
blood
cultur
record
incid
bacteri
coinfect
may
therefor
underestim
reflect
poor
sensit
lower
respiratori
cultur
set
empir
antimicrobi
therapi
bacteri
coinfect
associ
higher
mortal
despit
fact
cohort
receiv
antibacteri
drug
hospit
pathogenesi
influenza
bacteri
coinfect
synergist
complex
diseas
process
involv
numer
viral
bacteri
virul
factor
interact
host
immun
system
advers
affect
respiratori
physiolog
pandem
season
compar
usual
epidem
season
high
proport
mortal
influenza
infect
often
complic
bacteri
coinfect
occur
young
previous
healthi
peopl
result
aberr
immun
respons
viru
aureu
common
speci
isol
cohort
studi
coinfect
sever
ill
patient
influenza
infect
us
icu
aureu
also
found
common
bacteri
pathogen
pneumonia
h
influenza
pyogen
also
present
among
communityacquir
pathogen
surprisingli
p
aeruginosa
common
speci
p
aeruginosa
increasingli
describ
copathogen
influenza
expect
record
high
preval
gram
neg
coinfect
among
hospitalacquir
infect
cohort
hospitalacquir
coinfect
due
aureu
due
pseudomona
speci
enterobacteriacea
studi
evalu
agent
hospitalacquir
bacteri
pneumonia
without
underli
influenza
infect
attribut
aureu
attribut
p
aeruginosa
attribut
enterobacteriacea
preval
aureu
among
hospitalacquir
bacteri
coinfect
cohort
slightli
higher
would
expect
patient
without
influenza
infect
coinfect
result
greater
resourc
alloc
measur
hospit
length
stay
icu
length
stay
bivari
multivari
analysi
moreov
time
symptom
onset
administr
antivir
effect
influenza
delay
coinfect
patient
bivari
multivari
analysi
number
studi
shown
associ
earli
effect
antivir
use
influenza
infect
reduc
icu
admiss
mortal
suggest
delay
cohort
may
detriment
risk
factor
bacteri
coinfect
includ
lack
cardiovascular
diseas
well
leukocytosi
increas
sofa
score
icu
admiss
unclear
cardiovascular
diseas
appear
protect
cohort
may
statin
use
confer
antiinflammatori
immunomodulatori
effect
may
reduc
risk
coinfect
possibl
associ
warrant
studi
viral
coinfect
associ
increas
mortal
cohort
bivari
multivari
analysi
control
underli
comorbid
studi
evalu
previous
mix
associ
viral
coinfect
mortal
requir
research
studi
sever
limit
major
subject
treat
us
tertiari
care
center
thu
find
may
generaliz
popul
sever
ill
influenza
patient
includ
subject
admit
april
therefor
includ
final
part
influenza
season
like
exclud
disproportion
patient
sever
influenza
b
infect
may
experi
differ
risk
bacteri
viral
coinfect
influenza
pdm
patient
manag
patient
bacteri
identif
suscept
test
standard
rapid
diagnost
test
may
result
miss
case
influenza
among
icu
patient
howev
sole
method
use
studi
hospit
use
standard
data
collect
form
variabl
avail
subject
final
retrospect
studi
select
bia
immort
time
bia
may
affect
choic
subject
analysi
respect
studi
highlight
import
bacteri
coinfect
pathogenesi
sever
influenza
infect
prevent
measur
address
coinfect
includ
ensur
high
rate
influenza
pneumonia
h
influenza
vaccin
appropri
time
antivir
earli
appropri
antibiot
therapi
target
mrsa
pseudomona
therapi
target
mrsa
particularli
case
communityacquir
pneumonia
import
understand
complex
synergist
relationship
bacteria
influenza
vital
decreas
mortal
futur
season
pandem
influenza
season
